Cargando…
Structural and functional brain alterations in patients with myasthenia gravis
Myasthenia gravis is an autoimmune disease affecting neuromuscular transmission and causing skeletal muscle weakness. Additionally, systemic inflammation, cognitive deficits and autonomic dysfunction have been described. However, little is known about myasthenia gravis-related reorganization of the...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8856136/ https://www.ncbi.nlm.nih.gov/pubmed/35198977 http://dx.doi.org/10.1093/braincomms/fcac018 |
_version_ | 1784653780371898368 |
---|---|
author | Klaus, Benita Müller, Patrick van Wickeren, Nora Dordevic, Milos Schmicker, Marlen Zdunczyk, Yael Brigadski, Tanja Leßmann, Volkmar Vielhaber, Stefan Schreiber, Stefanie Müller, Notger G. |
author_facet | Klaus, Benita Müller, Patrick van Wickeren, Nora Dordevic, Milos Schmicker, Marlen Zdunczyk, Yael Brigadski, Tanja Leßmann, Volkmar Vielhaber, Stefan Schreiber, Stefanie Müller, Notger G. |
author_sort | Klaus, Benita |
collection | PubMed |
description | Myasthenia gravis is an autoimmune disease affecting neuromuscular transmission and causing skeletal muscle weakness. Additionally, systemic inflammation, cognitive deficits and autonomic dysfunction have been described. However, little is known about myasthenia gravis-related reorganization of the brain. In this study, we thus investigated the structural and functional brain changes in myasthenia gravis patients. Eleven myasthenia gravis patients (age: 70.64 ± 9.27; 11 males) were compared to age-, sex- and education-matched healthy controls (age: 70.18 ± 8.98; 11 males). Most of the patients (n = 10, 0.91%) received cholinesterase inhibitors. Structural brain changes were determined by applying voxel-based morphometry using high-resolution T(1)-weighted sequences. Functional brain changes were assessed with a neuropsychological test battery (including attention, memory and executive functions), a spatial orientation task and brain-derived neurotrophic factor blood levels. Myasthenia gravis patients showed significant grey matter volume reductions in the cingulate gyrus, in the inferior parietal lobe and in the fusiform gyrus. Furthermore, myasthenia gravis patients showed significantly lower performance in executive functions, working memory (Spatial Span, P = 0.034, d = 1.466), verbal episodic memory (P = 0.003, d = 1.468) and somatosensory-related spatial orientation (Triangle Completion Test, P = 0.003, d = 1.200). Additionally, serum brain-derived neurotrophic factor levels were significantly higher in myasthenia gravis patients (P = 0.001, d = 2.040). Our results indicate that myasthenia gravis is associated with structural and functional brain alterations. Especially the grey matter volume changes in the cingulate gyrus and the inferior parietal lobe could be associated with cognitive deficits in memory and executive functions. Furthermore, deficits in somatosensory-related spatial orientation could be associated with the lower volumes in the inferior parietal lobe. Future research is needed to replicate these findings independently in a larger sample and to investigate the underlying mechanisms in more detail. |
format | Online Article Text |
id | pubmed-8856136 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-88561362022-02-22 Structural and functional brain alterations in patients with myasthenia gravis Klaus, Benita Müller, Patrick van Wickeren, Nora Dordevic, Milos Schmicker, Marlen Zdunczyk, Yael Brigadski, Tanja Leßmann, Volkmar Vielhaber, Stefan Schreiber, Stefanie Müller, Notger G. Brain Commun Original Article Myasthenia gravis is an autoimmune disease affecting neuromuscular transmission and causing skeletal muscle weakness. Additionally, systemic inflammation, cognitive deficits and autonomic dysfunction have been described. However, little is known about myasthenia gravis-related reorganization of the brain. In this study, we thus investigated the structural and functional brain changes in myasthenia gravis patients. Eleven myasthenia gravis patients (age: 70.64 ± 9.27; 11 males) were compared to age-, sex- and education-matched healthy controls (age: 70.18 ± 8.98; 11 males). Most of the patients (n = 10, 0.91%) received cholinesterase inhibitors. Structural brain changes were determined by applying voxel-based morphometry using high-resolution T(1)-weighted sequences. Functional brain changes were assessed with a neuropsychological test battery (including attention, memory and executive functions), a spatial orientation task and brain-derived neurotrophic factor blood levels. Myasthenia gravis patients showed significant grey matter volume reductions in the cingulate gyrus, in the inferior parietal lobe and in the fusiform gyrus. Furthermore, myasthenia gravis patients showed significantly lower performance in executive functions, working memory (Spatial Span, P = 0.034, d = 1.466), verbal episodic memory (P = 0.003, d = 1.468) and somatosensory-related spatial orientation (Triangle Completion Test, P = 0.003, d = 1.200). Additionally, serum brain-derived neurotrophic factor levels were significantly higher in myasthenia gravis patients (P = 0.001, d = 2.040). Our results indicate that myasthenia gravis is associated with structural and functional brain alterations. Especially the grey matter volume changes in the cingulate gyrus and the inferior parietal lobe could be associated with cognitive deficits in memory and executive functions. Furthermore, deficits in somatosensory-related spatial orientation could be associated with the lower volumes in the inferior parietal lobe. Future research is needed to replicate these findings independently in a larger sample and to investigate the underlying mechanisms in more detail. Oxford University Press 2022-02-01 /pmc/articles/PMC8856136/ /pubmed/35198977 http://dx.doi.org/10.1093/braincomms/fcac018 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the Guarantors of Brain. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Klaus, Benita Müller, Patrick van Wickeren, Nora Dordevic, Milos Schmicker, Marlen Zdunczyk, Yael Brigadski, Tanja Leßmann, Volkmar Vielhaber, Stefan Schreiber, Stefanie Müller, Notger G. Structural and functional brain alterations in patients with myasthenia gravis |
title | Structural and functional brain alterations in patients with myasthenia gravis |
title_full | Structural and functional brain alterations in patients with myasthenia gravis |
title_fullStr | Structural and functional brain alterations in patients with myasthenia gravis |
title_full_unstemmed | Structural and functional brain alterations in patients with myasthenia gravis |
title_short | Structural and functional brain alterations in patients with myasthenia gravis |
title_sort | structural and functional brain alterations in patients with myasthenia gravis |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8856136/ https://www.ncbi.nlm.nih.gov/pubmed/35198977 http://dx.doi.org/10.1093/braincomms/fcac018 |
work_keys_str_mv | AT klausbenita structuralandfunctionalbrainalterationsinpatientswithmyastheniagravis AT mullerpatrick structuralandfunctionalbrainalterationsinpatientswithmyastheniagravis AT vanwickerennora structuralandfunctionalbrainalterationsinpatientswithmyastheniagravis AT dordevicmilos structuralandfunctionalbrainalterationsinpatientswithmyastheniagravis AT schmickermarlen structuralandfunctionalbrainalterationsinpatientswithmyastheniagravis AT zdunczykyael structuralandfunctionalbrainalterationsinpatientswithmyastheniagravis AT brigadskitanja structuralandfunctionalbrainalterationsinpatientswithmyastheniagravis AT leßmannvolkmar structuralandfunctionalbrainalterationsinpatientswithmyastheniagravis AT vielhaberstefan structuralandfunctionalbrainalterationsinpatientswithmyastheniagravis AT schreiberstefanie structuralandfunctionalbrainalterationsinpatientswithmyastheniagravis AT mullernotgerg structuralandfunctionalbrainalterationsinpatientswithmyastheniagravis |